• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Immune Pharmaceuticals - Articles and news items

bertilimumab

Immune Pharmaceuticals initiates Phase II trials of bertilimumab in ulcerative colitis and bullous pemphigoid

Industry news / 26 June 2015 / Victoria White

Immune Pharmaceuticals has initiated a Phase II trial of bertilimumab in ulcerative colitis and will initiate a Phase II bullous pemphigoid trial in July…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +